[go: up one dir, main page]

BE891129A - NEW GALENIC FORM OF FENOFIBRATE, ITS PROCESS FOR OBTAINING ITS APPLICATION AS A MEDICINE - Google Patents

NEW GALENIC FORM OF FENOFIBRATE, ITS PROCESS FOR OBTAINING ITS APPLICATION AS A MEDICINE

Info

Publication number
BE891129A
BE891129A BE1/10357A BE1010357A BE891129A BE 891129 A BE891129 A BE 891129A BE 1/10357 A BE1/10357 A BE 1/10357A BE 1010357 A BE1010357 A BE 1010357A BE 891129 A BE891129 A BE 891129A
Authority
BE
Belgium
Prior art keywords
fenofibrate
medicine
obtaining
application
galenic form
Prior art date
Application number
BE1/10357A
Other languages
French (fr)
Inventor
C Laruelle
Original Assignee
Laruelle Claude
Deshors
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laruelle Claude, Deshors filed Critical Laruelle Claude
Publication of BE891129A publication Critical patent/BE891129A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
BE1/10357A 1980-11-19 1981-11-16 NEW GALENIC FORM OF FENOFIBRATE, ITS PROCESS FOR OBTAINING ITS APPLICATION AS A MEDICINE BE891129A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8024568A FR2494112B1 (en) 1980-11-19 1980-11-19

Publications (1)

Publication Number Publication Date
BE891129A true BE891129A (en) 1982-05-17

Family

ID=9248140

Family Applications (1)

Application Number Title Priority Date Filing Date
BE1/10357A BE891129A (en) 1980-11-19 1981-11-16 NEW GALENIC FORM OF FENOFIBRATE, ITS PROCESS FOR OBTAINING ITS APPLICATION AS A MEDICINE

Country Status (8)

Country Link
EP (1) EP0065531A1 (en)
AT (1) AT387517B (en)
BE (1) BE891129A (en)
DE (1) DE3152519C2 (en)
FR (1) FR2494112B1 (en)
IT (1) IT1144948B (en)
NL (1) NL8120434A (en)
WO (1) WO1982001649A1 (en)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2554718B1 (en) * 1983-11-14 1986-04-04 Ethypharm Sa NEW ORAL SULPIRIDE FORMS FOR SULPIRIDE
FR2556964A1 (en) * 1983-12-23 1985-06-28 Ile De France NEW GALENIC FORMS OF SULPIRIDE USED ORALALLY
JPS60221078A (en) * 1984-04-18 1985-11-05 Morinaga Milk Ind Co Ltd Granular product of useful microorganism powder and its preparation
IT1180507B (en) * 1984-06-29 1987-09-23 Roberto Valducci PROCEDURE FOR THE PREPARATION OF ETOFIBRATE OR SUBSTANCES OF EQUAL OR SIMILAR CHARACTERISTICS, IN MICROGUNULI-DELAY AND PRODUCT OBTAINED WITH SUCH PROCEDURE
FR2602423B1 (en) * 1986-08-08 1989-05-05 Ethypharm Sa PROCESS FOR THE PREPARATION OF A FENOFIBRATE-BASED MEDICINAL PRODUCT, OBTAINED BY THIS PROCESS
FR2627696B1 (en) * 1988-02-26 1991-09-13 Fournier Innovation Synergie NEW GALENIC FORM OF FENOFIBRATE
FR2737121B1 (en) * 1995-07-27 1997-10-03 Cl Pharma NEW GALENIC FORMULATIONS OF FENOFIBRATE AND THEIR APPLICATIONS
DE19608750A1 (en) * 1996-03-06 1997-09-11 Durachemie Gmbh & Co Kg Process for the production of fenofibrate preparations
FR2758459B1 (en) * 1997-01-17 1999-05-07 Pharma Pass FENOFIBRATE PHARMACEUTICAL COMPOSITION HAVING HIGH BIODAVAILABILITY AND PROCESS FOR PREPARING THE SAME
FR2758461A1 (en) * 1997-01-17 1998-07-24 Pharma Pass PHARMACEUTICAL COMPOSITION HAVING HIGH BIOAVAILABILITY AND PROCESS FOR PREPARING THE SAME
US6814977B1 (en) 1998-12-18 2004-11-09 Abbott Laboratories Formulations comprising lipid-regulating agents
US7014864B1 (en) 1998-12-18 2006-03-21 Abbott Laboratories Formulations comprising lipid-regulating agents
US6838091B2 (en) 1998-12-18 2005-01-04 Abbott Laboratories Formulations comprising lipid-regulating agents
DE19858789A1 (en) 1998-12-18 2000-06-21 Bayer Ag Medicament combination of cerivastatin and fibrate, has additive effect in the treatment of lipid metabolism disorders, e.g. dyslipidemia or atherosclerosis
US6180138B1 (en) 1999-01-29 2001-01-30 Abbott Laboratories Process for preparing solid formulations of lipid-regulating agents with enhanced dissolution and absorption
US6383517B1 (en) 1999-01-29 2002-05-07 Abbott Laboratories Process for preparing solid formulations of lipid-regulating agents with enhanced dissolution and absorption
US6368622B2 (en) 1999-01-29 2002-04-09 Abbott Laboratories Process for preparing solid formulations of lipid regulating agents with enhanced dissolution and absorption
US6719999B2 (en) 1999-03-31 2004-04-13 Abbott Laboratories Formulations comprising lipid-regulating agents
US6465011B2 (en) 1999-05-29 2002-10-15 Abbott Laboratories Formulations comprising lipid-regulating agents
US6372251B2 (en) 1999-06-11 2002-04-16 Abbott Laboratories Formulations comprising lipid-regulating agents
US6982281B1 (en) 2000-11-17 2006-01-03 Lipocine Inc Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
US7863331B2 (en) 1999-07-09 2011-01-04 Ethypharm Pharmaceutical composition containing fenofibrate and method for the preparation thereof
FR2795961B1 (en) 1999-07-09 2004-05-28 Ethypharm Lab Prod Ethiques PHARMACEUTICAL COMPOSITION CONTAINING MICRONIZED FENOFIBRATE, A SURFACTANT AND A BINDING CELLULOSIC DERIVATIVE AND PREPARATION METHOD
US6531158B1 (en) 2000-08-09 2003-03-11 Impax Laboratories, Inc. Drug delivery system for enhanced bioavailability of hydrophobic active ingredients
US6982251B2 (en) 2000-12-20 2006-01-03 Schering Corporation Substituted 2-azetidinones useful as hypocholesterolemic agents
FR2819720B1 (en) 2001-01-22 2004-03-12 Fournier Lab Sa NEW FENOFIBRATE TABLETS
IL156445A0 (en) 2001-01-26 2004-01-04 Schering Corp Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications
SI1355644T1 (en) 2001-01-26 2006-10-31 Schering Corp The use of substituted azetidinone compounds for the treatment of sitosterolemia
US7071181B2 (en) 2001-01-26 2006-07-04 Schering Corporation Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
US7053080B2 (en) 2001-09-21 2006-05-30 Schering Corporation Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
DK1429756T3 (en) 2001-09-21 2007-03-19 Schering Corp Treatment of xanthoma with azetidinone derivatives as sterol absorption inhibitors
US7056906B2 (en) 2001-09-21 2006-06-06 Schering Corporation Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
WO2004028506A1 (en) * 2002-09-24 2004-04-08 Ranbaxy Laboratories Limited Oral pharmaceutical compositions of fenofibrate having high bioavailability
US20040092499A1 (en) 2002-11-06 2004-05-13 Schering Corporation Methods and therapeutic combinations for the treatment of autoimmune disorders
US20060165674A1 (en) * 2002-11-22 2006-07-27 Toshikazu Koyama Granular composition and process for producing the same
EP1829541A1 (en) * 2002-12-17 2007-09-05 Abbott GmbH & Co. KG Formulation comprising fenofibric acid or a physiologically acceptable salt thereof
WO2004054568A1 (en) * 2002-12-17 2004-07-01 Abbott Gmbh & Co. Kg Formulation comprising fenofibric acid, a physiologically acceptable salt or derivative thereof
WO2004081002A1 (en) 2003-03-07 2004-09-23 Schering Corporation Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia
US7459442B2 (en) 2003-03-07 2008-12-02 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
ATE418551T1 (en) 2003-03-07 2009-01-15 Schering Corp SUBSTITUTED AZETIDINONE DERIVATIVES, THEIR PHARMACEUTICAL FORMULATIONS AND THEIR USE IN THE TREATMENT OF HYPERCHOLESTEROLEMIA
CN1756755A (en) 2003-03-07 2006-04-05 先灵公司 Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia
JP5134818B2 (en) * 2003-07-02 2013-01-30 アボット・ラボラトリーズ Method for the manufacture of lipid controlled drug formulations
US8062664B2 (en) 2003-11-12 2011-11-22 Abbott Laboratories Process for preparing formulations of lipid-regulating drugs
EP1785133A1 (en) 2005-11-10 2007-05-16 Laboratoires Fournier S.A. Use of fenofibrate or a derivative thereof for preventing diabetic retinopathy
WO2008075320A2 (en) * 2006-12-21 2008-06-26 Ranbaxy Laboratories Limited Antilipidemic pharmaceutical compositions and process for preparation thereof
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
US20170246187A1 (en) 2014-08-28 2017-08-31 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
US9498485B2 (en) 2014-08-28 2016-11-22 Lipocine Inc. Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
WO2016205423A2 (en) 2015-06-15 2016-12-22 Lipocine Inc. Composition and method for oral delivery of androgen prodrugs
CA3078723A1 (en) 2016-11-28 2018-05-31 Nachiappan Chidambaram Oral testosterone undecanoate therapy
US12150945B2 (en) 2018-07-20 2024-11-26 Lipocine Inc. Liver disease

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2963402A (en) * 1955-01-18 1960-12-06 Nysco Lab Inc Sustained release medicament
FR1347413A (en) * 1963-01-29 1963-12-27 Italnysco S P A Broad-acting spherules or globules and method for their preparation
GB1415295A (en) * 1971-10-14 1975-11-26 Orchimed Sa Substituted phenoxy-alkyl-carboxylic acids and derivatives thereof
DE2336218C3 (en) * 1973-07-17 1985-11-14 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Oral dosage form
FR2313915A1 (en) * 1976-01-26 1977-01-07 Corneille Gilbert Sustained release vincamine microcapsules - with inert core, vincamine (deriv.) intermediate layer and microporous outer coating
LU77353A1 (en) * 1977-05-16 1979-01-19
FR2432313A1 (en) * 1978-08-01 1980-02-29 Foulhoux Pierre Micro:granules contg. beta-histine - for controlled release and less side effects useful in treating Menieres syndrome

Also Published As

Publication number Publication date
ATA906481A (en) 1988-07-15
IT1144948B (en) 1986-10-29
EP0065531A1 (en) 1982-12-01
DE3152519T1 (en) 1983-12-29
FR2494112A1 (en) 1982-05-21
AT387517B (en) 1989-02-10
NL8120434A (en) 1982-10-01
DE3152519C2 (en) 1990-11-22
FR2494112B1 (en) 1986-01-10
WO1982001649A1 (en) 1982-05-27
IT8125185A0 (en) 1981-11-19

Similar Documents

Publication Publication Date Title
BE891129A (en) NEW GALENIC FORM OF FENOFIBRATE, ITS PROCESS FOR OBTAINING ITS APPLICATION AS A MEDICINE
MA19639A1 (en) Process for the preparation of derivatives of cis, endo-2-azabicyclo- (3,3,0) -octane-3-carboxylic acid and agents containing these derivatives
BE876815A (en) SYNTHETIC POLYMER, PROCESS FOR OBTAINING AND APPLICATION AS A SOOTHING AGENT
BE866807A (en) NEW GLYCOPROTEIN, ITS OBTAINING PROCESS AND ITS THERAPEUTIC APPLICATION
BE876262A (en) PROCESS FOR PREPARING THE (S, 5S) ACID - -AMINO-3-CHLORO-ISOXAZOLINE-5-ACETIC, NEW ANALOGUES OF THIS ACID, AND PREPARATION OF THESE ANALOGUES
RO77557A (en) PROCESS FOR THE CONTINUOUS PREPARATION OF 1,4-BUTANDIOL
RO74872A2 (en) PROCESS FOR OBTAINING A BIOLOGICALLY ACTIVE APICOLIC PRODUCT
BE854102A (en) DERIVATIVES OF DESAMINATION OF THE TRYPSINEKALLIKREIN INHIBITOR, PROCESS FOR THEIR PRODUCTION AND THEIR APPLICATION AS A MEDICINAL PRODUCT
MA18832A1 (en) NOVEL TRITERPENIC SAPONIN, PROCESS FOR OBTAINING IT, AND USE THEREOF AS A MEDICINAL PRODUCT
BE872958A (en) CONTINUOUS PROCESS FOR THE PRODUCTION OF ALKYLENEGLYCOLS FROM ALKYLENE CARBONATES
BE881550A (en) MIXTURE OF 2- (4-CHLOROPHENYL) -ISOVALERATE OF ALPHA-CYANO-3- (4-HALOGENOPHENOXY) -BENZYLE STEREOISOMERS, PROCESS FOR PREPARING THE SAME AND COMPOSITION THEREOF
RO77772A (en) PROCESS FOR THE PREPARATION OF 2,2-DIMETHYLCYCLOPROPANCARBOXYLIC ACID DERIVATIVES
FR2647346B1 (en) STABILIZED PROGESTERONE COMPOUND, PROCESS FOR PREPARING THE SAME, AND USE OF THE COMPOUND FOR OBTAINING A MEDICAMENT
FR2574429B1 (en) ACYLGLYCANNES EXTRACTED FROM KLEBSIELLA, PROCESS FOR OBTAINING THEM, THEIR APPLICATION AS MEDICAMENTS AND THE COMPOSITIONS CONTAINING THEM
FR2515961B1 (en) DRUG PREPARATIONS CONTAINING A TETRAIODOTHYROCARBOXYLIC ACID DERIVATIVE, PARTICULARLY FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA
BE864122A (en) COMPOSITION OF PENTAPEPTIDE, ITS PROCESS FOR OBTAINING AND THERAPEUTIC COMPOSITION BY CONTAINING
BE867228A (en) PROCESS FOR THE PREPARATION OF HYDROXYPHENYLGLYCOCOLLES
BE880031A (en) PROCESS FOR THE PREPARATION OF 1 ALPHA, 3 BETA-DIHYDROXY-DELTA 5-STEROIDES
BE865480A (en) PROCESS FOR THE PREPARATION OF NAPHTYLAMINOHYDROXYSULPHONIC ACIDS
FR2615185B1 (en) PROCESS FOR THE PREPARATION OF TRIFLUOROMETHYLTOLUENE FROM HALOMETHYLBENZOTRIFLUORIDE
BE871961A (en) IMPROVED PROCESS FOR THE PRODUCTION OF ALKYLENE-GLYCOLS
RO85817A (en) PROCESS FOR THE PREPARATION OF 2- (3-ARYLISOXAZOLE-5YL) -BENZOIC ACID HALIDES
FR2342986A1 (en) PROCESS FOR THE PREPARATION OF ACID HALOGENIDES (2-HALOGENOFORMYL) -VINYL) -ORGANYL-PHOSPHINICS
IT1095357B (en) PROCESS FOR THE PREPARATION OF BIS- (3 ', 5'-DI-T-BUTYL-4'-HYDROXY-FENYL) ACID ESTERS ALCHILCARBOSSILICI
PT67753A (en) PROCESS FOR THE PREPARATION OF A MEDICAMENT

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: LARUELLE CLAUDE

Effective date: 19931130